Latest News

2019 Specialty Pipeline Highlights
Keep an eye out for these specialty pipeline medications in 2019.
An inhaled medication for a disease that does not affect the lungs may prove to be a promising concept in the treatment of chronic diseases.
They may still suggest revisions to latest standards but must prepare regardless for new compounding regulations.
The new indication would allow treatment-experienced patients with HIV to switch to Pifeltro in combination with other HIV medications or Delstrigo.
Universal hepatitis screening may be warranted to identify patients with cancer who have undiagnosed viral infections.
This is the first time an anti-PD-1 therapy has demonstrated a survival benefit in this patient population.
Although the leading treatment for hemophilia is a replacement therapy in the form of both plasma-derived and rF products, research is underway for the discovery of novel agents.


How Can We Advance Progress in Moving From Volume to Value in Health Care?
It is critical that we continue to recognize that better health outcomes are a critically important corollary to value.
There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.
For a current compounder or someone looking to enter the space, it is imperative that their business remains on top of the latest compounding developments.
Unfortunately, there is no way to stop a category 5 hurricane, but it doesn’t have to result in catastrophe for patients.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, gives an overview of the exciting therapeutic developments in the B-cell lymphoma space.

Nick Calla, RPh, vice president of Industry Relations at Cardinal Health Specialty Solutions, talks about how technology can enhance patient care from a pharmacy perspective.

Current Issue

Volume: 10
Number: 1

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.